Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
POLICY PAPERS
April 15, 2024
WORKING PAPERS
April 15, 2024
CGD NOTES
April 11, 2024
WORKING PAPERS
April 11, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
CGD NOTES
April 07, 2022
While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...
CGD NOTES
March 30, 2022
The IMF is on track to establish its new lending vehicle—the “Resilience and Sustainability Trust (RST)”—that aims to re-channel some $50 billion of newly allocated special drawing rights (SDRs) from rich to developing countries. But there is a catch: the proposed conditions for accessing funds coul...
CGD NOTES
March 29, 2022
IMF and World Bank 2022 growth projections for emerging markets and developing economies (EMDEs), released in January this year, were not encouraging. They found that deteriorated macroeconomic fundamentals, partly resulting from policy responses to the pandemic, deep institutional deficiencies, and...
CGD NOTES
March 14, 2022
In the face of sudden economic shocks and natural disasters that limit the ability of economies to rapidly raise revenue, MDBs have the potential to play a leading role in crisis response to minimize the damage. One key factor in their success in this role is the speed of their financing instruments...
CGD NOTES
March 08, 2022
Governments have implemented an array of interventions needed to contain the economic impacts of COVID-19. Some of these interventions are not adequately captured in traditional fiscal metrics, such as debt and deficit. One approach to ensuring comprehensive coverage of these interventions and to pr...
CGD NOTES
March 03, 2022
The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...
CGD NOTES
March 03, 2022
Corrective taxes on harmful products—health taxes—are a cost-effective way to save lives and generate additional tax revenue. In new research, we show that health tax measures during COVID-19 have diminished in number and strength because the international community has mobilized additional, largely...